Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

Clinical trial NCT00214773 · COMPLETED

Trial details

NCT number: NCT00214773
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Study type: OBSERVATIONAL

Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)

Start date: 2005-07-01
Primary completion: 2020-05-01
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.